Li G - Search Results

1

Arylation of α-pivaloxyl ketones with arylboronic reagents via Ni-catalyzed sp3 C-O activation.

Huang K, Li G, Huang WP, Yu DG, Shi ZJ. Huang K, et al. Among authors: li g. Chem Commun (Camb). 2011 Jul 7;47(25):7224-6. doi: 10.1039/c1cc11193k. Epub 2011 May 27. Chem Commun (Camb). 2011. PMID: 21623433

2

Bleeds and imaging scoring scales in relation to pharmacokinetics of coagulation factor VIII in Chinese pediatric patients with severe hemophilia A.

Huang K, Chen Z, Li G, Zhen Y, Wu X, Zhang N, Wu R. Huang K, et al. Among authors: li g. Thromb Res. 2020 Sep;193:83-85. doi: 10.1016/j.thromres.2020.05.043. Epub 2020 May 28. Thromb Res. 2020. PMID: 32531547 No abstract available.

3

Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study.

Huang K, Li G, Zhen Y, Wu X, Chen Z, Wu R. Huang K, et al. Among authors: li g. Haemophilia. 2021 Mar;27(2):e287-e290. doi: 10.1111/hae.14163. Epub 2020 Sep 30. Haemophilia. 2021. PMID: 32997865 No abstract available.

4

Pharmacokinetic study of Kovaltry in thirty-five pediatric patients aged <12 years with severe hemophilia A.

Huang K, Zhen Y, Li G, Wu X, Wu R, Chen Z. Huang K, et al. Among authors: li g. Haemophilia. 2021 May;27(3):e340-e346. doi: 10.1111/hae.14276. Epub 2021 Mar 1. Haemophilia. 2021. PMID: 33645868

5

Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A.

Chen Z, Huang K, Li G, Zhen Y, Wu X, Di A, Liu G, Li Z, Alfonso I, Wu R. Chen Z, et al. Among authors: li z, li g. Pediatr Investig. 2021 Mar 22;5(1):38-45. doi: 10.1002/ped4.12252. eCollection 2021 Mar. Pediatr Investig. 2021. PMID: 33778426 Free PMC article.

6

Pharmacokinetic-guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A.

Huang K, Zhen Y, Li G, Wu X, Chen Z, Wu R. Huang K, et al. Among authors: li g. Haemophilia. 2021 Jul;27(4):e450-e457. doi: 10.1111/hae.14336. Epub 2021 May 20. Haemophilia. 2021. PMID: 34015176

7

Nephrotic syndrome in two haemophilia B children with inhibitor under low-dose immune tolerance induction combined with rituximab-based immunosuppressant protocol.

Li Z, Liu G, Yao W, Chen Z, Li G, Cheng X, Zhen Y, Ai D, Huang K, Poon MC, Wu R. Li Z, et al. Among authors: li g. Haemophilia. 2022 Mar;28(2):e42-e45. doi: 10.1111/hae.14471. Epub 2021 Dec 22. Haemophilia. 2022. PMID: 34936170 No abstract available.

8

Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A.

Huang K, Wang Y, Zhen Y, Li G, Wu X, Zhang N, Chen Z, Wu R. Huang K, et al. Among authors: li g. Thromb Res. 2022 May;213:71-77. doi: 10.1016/j.thromres.2022.03.008. Epub 2022 Mar 12. Thromb Res. 2022. PMID: 35305529

9

Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half-life factor VIII concentrates.

Huang K, Zhen Y, Li G, Wu X, Chen Z, Wu R. Huang K, et al. Among authors: li g. Res Pract Thromb Haemost. 2022 Mar 25;6(2):e12686. doi: 10.1002/rth2.12686. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35356665 Free PMC article.

10

Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China.

Li Z, Liu G, Yao W, Chen Z, Li G, Cheng X, Zhen Y, Ai D, Huang K, Sun J, Poon MC, Wu R. Li Z, et al. Among authors: li g. Haemophilia. 2022 Jul;28(4):625-632. doi: 10.1111/hae.14577. Epub 2022 May 3. Haemophilia. 2022. PMID: 35503087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,451 results

Search Page

Filters